A Study of FB2001 for Inhalation in Healthy Chinese Adults

Clinical trial NCT05583812 · COMPLETED

Trial details

NCT number: NCT05583812
Sponsor: Frontier Biotechnologies Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Pandemic

Start date: 2022-10-21
Primary completion: 2022-12-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.